Cargando…

The predictive prognostic values of serum interleukin-2, interleukin-6, interleukin-8, tumor necrosis factor-α, and procalcitonin in surgical intensive care unit patients

BACKGROUND: The pathophysiological roles of serum cytokine levels in critically ill surgical patients has yet to be determined. This study aimed to determine the predictive prognostic values of serum interleukin IL-2, IL-6, IL-8, tumor necrosis factor-α (TNF-α), and procalcitonin (PCT) in surgical i...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Yamin, Hu, Yan, Wang, Xiaorong, Yu, Zhenghong, Tang, Yingjia, Zhang, Yuxia, Pan, Wenyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7859771/
https://www.ncbi.nlm.nih.gov/pubmed/33553349
http://dx.doi.org/10.21037/atm-20-6608
_version_ 1783646808046567424
author Yan, Yamin
Hu, Yan
Wang, Xiaorong
Yu, Zhenghong
Tang, Yingjia
Zhang, Yuxia
Pan, Wenyan
author_facet Yan, Yamin
Hu, Yan
Wang, Xiaorong
Yu, Zhenghong
Tang, Yingjia
Zhang, Yuxia
Pan, Wenyan
author_sort Yan, Yamin
collection PubMed
description BACKGROUND: The pathophysiological roles of serum cytokine levels in critically ill surgical patients has yet to be determined. This study aimed to determine the predictive prognostic values of serum interleukin IL-2, IL-6, IL-8, tumor necrosis factor-α (TNF-α), and procalcitonin (PCT) in surgical intensive care unit (ICU) patients. METHODS: Cytokine concentrations were measured with an IMMULITE 1000 Immunoassay System (Siemens Healthcare Diagnostics GmbH, Berlin, Germany). The study population was divided into quartiles according to the patients’ cytokine levels: Q1, Q2, Q3, and Q4. The optimal cutoff values of IL-2, IL-6, IL-8, TNF-α, and PCT level for predicting mortality were established by drawing receiver operating characteristic curves. RESULTS: The levels of IL-2 in Q3 [odds ratio (OR) =4.434, 95% confidence intervals (95% CI): 1.527–12.874] and Q4 (OR =7.715, 95% CI: 2.744–21.693) were significantly higher than those in the Q1. The same results were noted in IL-6 and IL-8, and only Q4 (OR =2.383, 95% CI: 1.419–4.001) showed significance in the level of TNF-α. For IL-2, a cutoff value of 930.5 U/mL yielded a sensitivity of 69.39% and a specificity of 80.16% for the prediction of clinical outcome [area under the curve (AUC): 0.822; 95% CI: 0.789–0.855]. For IL-6, a cutoff value of 50.95 pg/mL showed discrimination ability, yielding a sensitivity of 71.43% and a specificity of 61.75% for (AUC: 0.704; 95% CI: 0.660–0.748). For IL-8, a cutoff value of 44.1 pg/mL yielded a sensitivity of 57.82% and a specificity of 79.58% for predicting clinical outcome (AUC: 0.753; 95% CI: 0.713–0.793). For TNF-α, a cutoff value of 11.95 pg/mL yielded a sensitivity and specificity of 68.66% and 72.90%, respectively, in predicting clinical outcome (AUC: 0.758; 95% CI: 0.717–0.800). The positive likelihood ratios for IL-2, IL-6, IL-8, and TNF-α were 3.50, 1.87, 2.83 and 2.53, and the negative likelihood ratios were 0.38, 0.46, 0.53, and 0.43, respectively. CONCLUSIONS: In critically ill patients, high levels of IL-2, IL-6, IL-8, and TNF-α in the first 24 h postoperatively were associated with clinical outcome. However, the effect of PCT level on prognosis still requires further study.
format Online
Article
Text
id pubmed-7859771
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-78597712021-02-05 The predictive prognostic values of serum interleukin-2, interleukin-6, interleukin-8, tumor necrosis factor-α, and procalcitonin in surgical intensive care unit patients Yan, Yamin Hu, Yan Wang, Xiaorong Yu, Zhenghong Tang, Yingjia Zhang, Yuxia Pan, Wenyan Ann Transl Med Original Article BACKGROUND: The pathophysiological roles of serum cytokine levels in critically ill surgical patients has yet to be determined. This study aimed to determine the predictive prognostic values of serum interleukin IL-2, IL-6, IL-8, tumor necrosis factor-α (TNF-α), and procalcitonin (PCT) in surgical intensive care unit (ICU) patients. METHODS: Cytokine concentrations were measured with an IMMULITE 1000 Immunoassay System (Siemens Healthcare Diagnostics GmbH, Berlin, Germany). The study population was divided into quartiles according to the patients’ cytokine levels: Q1, Q2, Q3, and Q4. The optimal cutoff values of IL-2, IL-6, IL-8, TNF-α, and PCT level for predicting mortality were established by drawing receiver operating characteristic curves. RESULTS: The levels of IL-2 in Q3 [odds ratio (OR) =4.434, 95% confidence intervals (95% CI): 1.527–12.874] and Q4 (OR =7.715, 95% CI: 2.744–21.693) were significantly higher than those in the Q1. The same results were noted in IL-6 and IL-8, and only Q4 (OR =2.383, 95% CI: 1.419–4.001) showed significance in the level of TNF-α. For IL-2, a cutoff value of 930.5 U/mL yielded a sensitivity of 69.39% and a specificity of 80.16% for the prediction of clinical outcome [area under the curve (AUC): 0.822; 95% CI: 0.789–0.855]. For IL-6, a cutoff value of 50.95 pg/mL showed discrimination ability, yielding a sensitivity of 71.43% and a specificity of 61.75% for (AUC: 0.704; 95% CI: 0.660–0.748). For IL-8, a cutoff value of 44.1 pg/mL yielded a sensitivity of 57.82% and a specificity of 79.58% for predicting clinical outcome (AUC: 0.753; 95% CI: 0.713–0.793). For TNF-α, a cutoff value of 11.95 pg/mL yielded a sensitivity and specificity of 68.66% and 72.90%, respectively, in predicting clinical outcome (AUC: 0.758; 95% CI: 0.717–0.800). The positive likelihood ratios for IL-2, IL-6, IL-8, and TNF-α were 3.50, 1.87, 2.83 and 2.53, and the negative likelihood ratios were 0.38, 0.46, 0.53, and 0.43, respectively. CONCLUSIONS: In critically ill patients, high levels of IL-2, IL-6, IL-8, and TNF-α in the first 24 h postoperatively were associated with clinical outcome. However, the effect of PCT level on prognosis still requires further study. AME Publishing Company 2021-01 /pmc/articles/PMC7859771/ /pubmed/33553349 http://dx.doi.org/10.21037/atm-20-6608 Text en 2021 Annals of Translational Medicine. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Original Article
Yan, Yamin
Hu, Yan
Wang, Xiaorong
Yu, Zhenghong
Tang, Yingjia
Zhang, Yuxia
Pan, Wenyan
The predictive prognostic values of serum interleukin-2, interleukin-6, interleukin-8, tumor necrosis factor-α, and procalcitonin in surgical intensive care unit patients
title The predictive prognostic values of serum interleukin-2, interleukin-6, interleukin-8, tumor necrosis factor-α, and procalcitonin in surgical intensive care unit patients
title_full The predictive prognostic values of serum interleukin-2, interleukin-6, interleukin-8, tumor necrosis factor-α, and procalcitonin in surgical intensive care unit patients
title_fullStr The predictive prognostic values of serum interleukin-2, interleukin-6, interleukin-8, tumor necrosis factor-α, and procalcitonin in surgical intensive care unit patients
title_full_unstemmed The predictive prognostic values of serum interleukin-2, interleukin-6, interleukin-8, tumor necrosis factor-α, and procalcitonin in surgical intensive care unit patients
title_short The predictive prognostic values of serum interleukin-2, interleukin-6, interleukin-8, tumor necrosis factor-α, and procalcitonin in surgical intensive care unit patients
title_sort predictive prognostic values of serum interleukin-2, interleukin-6, interleukin-8, tumor necrosis factor-α, and procalcitonin in surgical intensive care unit patients
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7859771/
https://www.ncbi.nlm.nih.gov/pubmed/33553349
http://dx.doi.org/10.21037/atm-20-6608
work_keys_str_mv AT yanyamin thepredictiveprognosticvaluesofseruminterleukin2interleukin6interleukin8tumornecrosisfactoraandprocalcitonininsurgicalintensivecareunitpatients
AT huyan thepredictiveprognosticvaluesofseruminterleukin2interleukin6interleukin8tumornecrosisfactoraandprocalcitonininsurgicalintensivecareunitpatients
AT wangxiaorong thepredictiveprognosticvaluesofseruminterleukin2interleukin6interleukin8tumornecrosisfactoraandprocalcitonininsurgicalintensivecareunitpatients
AT yuzhenghong thepredictiveprognosticvaluesofseruminterleukin2interleukin6interleukin8tumornecrosisfactoraandprocalcitonininsurgicalintensivecareunitpatients
AT tangyingjia thepredictiveprognosticvaluesofseruminterleukin2interleukin6interleukin8tumornecrosisfactoraandprocalcitonininsurgicalintensivecareunitpatients
AT zhangyuxia thepredictiveprognosticvaluesofseruminterleukin2interleukin6interleukin8tumornecrosisfactoraandprocalcitonininsurgicalintensivecareunitpatients
AT panwenyan thepredictiveprognosticvaluesofseruminterleukin2interleukin6interleukin8tumornecrosisfactoraandprocalcitonininsurgicalintensivecareunitpatients
AT yanyamin predictiveprognosticvaluesofseruminterleukin2interleukin6interleukin8tumornecrosisfactoraandprocalcitonininsurgicalintensivecareunitpatients
AT huyan predictiveprognosticvaluesofseruminterleukin2interleukin6interleukin8tumornecrosisfactoraandprocalcitonininsurgicalintensivecareunitpatients
AT wangxiaorong predictiveprognosticvaluesofseruminterleukin2interleukin6interleukin8tumornecrosisfactoraandprocalcitonininsurgicalintensivecareunitpatients
AT yuzhenghong predictiveprognosticvaluesofseruminterleukin2interleukin6interleukin8tumornecrosisfactoraandprocalcitonininsurgicalintensivecareunitpatients
AT tangyingjia predictiveprognosticvaluesofseruminterleukin2interleukin6interleukin8tumornecrosisfactoraandprocalcitonininsurgicalintensivecareunitpatients
AT zhangyuxia predictiveprognosticvaluesofseruminterleukin2interleukin6interleukin8tumornecrosisfactoraandprocalcitonininsurgicalintensivecareunitpatients
AT panwenyan predictiveprognosticvaluesofseruminterleukin2interleukin6interleukin8tumornecrosisfactoraandprocalcitonininsurgicalintensivecareunitpatients